氧化镁使用与老年人髋部骨折风险:一项基于人群的回顾性队列分析
该研究利用台湾全民保险数据库,纳入经倾向评分匹配的氧化镁使用组与未使用组各26,069名老年人(>65岁),随访期间氧化镁组髋部骨折累积发生率显著更高(1.23/100人年 vs 0.74/100人年),多变量调整后氧化镁使用是髋部骨折的独立危险因素(aHR 1.66, 95%CI 1.54-1.80, p<0.001)。
要点
- 氧化镁使用与老年人髋部骨折风险独立相关(aHR 1.66, 95%CI 1.54-1.80)。
- 氧化镁组髋部骨折累积发生率为1.23/100人年,高于非使用组的0.74/100人年。
- 需进一步研究探索氧化镁导致髋部骨折的机制。
核心结论
- 氧化镁使用是老年人髋部骨折的独立危险因素。
研究设计与样本
- 基于台湾全民保险 claims 的全国性人群回顾性队列研究,1996–2013年开展。
- 经倾向评分匹配纳入氧化镁使用组(n=26,069)与未使用组(n=26,069),年龄>65岁。
主要发现
- 氧化镁组平均随访4.8年,非使用组5.7年,分别发生1547例和1107例髋部骨折。
- 单变量分析中氧化镁使用的粗HR为1.68(95%CI 1.55-1.81, p<0.001)。
- 多变量分析调整年龄、性别、合并症和药物后,aHR为1.66(95%CI 1.54-1.80, p<0.001)。
- 氧化镁组髋部骨折累积发生率为1.23/100人年,非使用组为0.74/100人年(logrank检验 p<0.001)。
临床怎么用
- 对老年人使用氧化镁时应评估髋部骨折风险,并加强骨健康监测。
局限性
- 研究为回顾性队列设计,可能存在残余混杂。
- 氧化镁导致髋部骨折的机制尚不明确,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Using national insurance claims of Taiwan, we found that magnesium oxide (MgO) use is associated with an increased risk of hip fracture in the elderly. Further studies are warranted to explore the mechanisms associated with MgO use that lead to hip fracture. PURPOSE: The purpose of this study was to investigate the association between MgO use and hip fracture risk in the elderly (age > 65 years). METHODS: This nationwide population-based retrospective study was conducted from 1996 to 2013. Individuals with (n = 26,069) and without (n = 26,069) MgO use were enrolled after propensity score matching. Primary outcome was a hip fracture. After adjusting for age, sex, comorbidities, and medications, multivariate Cox proportional hazards regression models were used to calculate incidences and risk of hip fracture [hazard ratio (HR)]. RESULTS: During the mean follow-up duration of 4.8 years in the MgO cohort and 5.7 years in the non-MgO cohort, respectively 1547 and 1107 cases developed a hip fracture. MgO use was identified as a risk factor for hip fracture in both univariate [crude HR, 1.68; 95% confidence interval (CI), 1.55-1.81; p < 0.001] and multivariate [adjusted HR (aHR), 1.66; 95% CI, 1.54-1.80; p < 0.001] Cox proportional hazards regression models. The cumulative incidence of hip fracture was significantly higher in the MgO cohort than in the non-MgO cohort (1.23 per 100 person-years vs. 0.74 per 100 person-years, logrank test, p < 0.001). CONCLUSION: MgO use is an independent risk factor for hip fracture in the elderly.
引用
- Wu YY, Chang CL, Wang JH, et al. Magnesium oxide and hip fracture in the elderly: a population-based retrospective cohort analysis. Osteoporos Int. 2020. PMID: 31960100. doi:10.1007/s00198-020-05278-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。